// App-Quantinova.ai

3079 : Rapid cell expansion (RACE) technology for production of engineered autologous T-cell therapy: Path toward manageable multicenter clinical trials in aggressive NHL with anti-CD19 CAR.

Researchers

Presenter

  • Marc Better

Principal Investigators

  • Omar Pugach

  • Lily Lu

  • James Kochenderfer

  • Steven A. Rosenberg

  • Margaret A. Marshall

  • Adrian Bot

  • Keith B. Nolop

  • Margo Roberts

  • Steven Feldman

  • Robert Somerville

  • Sadik Kassim

Medical Centers

  • Kite Pharma, Santa Monica, CA

  • Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, MDSurgery Branch, National Cancer Institute, Bethesda, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Alpha-methylacyl-CoA racemase

  • Peripheral blood mononuclear cell

  • Coxsackie Virus And Adenovirus Receptor

  • Interleukin-2

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved